Skip to Main Content

Paper Details

Combined Inhibition of Gα<sub>q</sub> and MEK Enhances Therapeutic Efficacy in Uveal Melanoma.
Clin Cancer Res
27
2021
CYSLTR2, G-protein alpha-q, G48V, GNAQ, Gq, L129Q, MAPK, MEK, Q209L, R183Q, Uveal Melanoma, YM-254890, human, human uveal melanoma, human uveal melanoma cell lines, human uveal melanoma xenografts, isogenic melanocytic cellular system, melanocytic cellular system, melanoma, melanomas, tumor, uveal melanoma
Author NameAffiliation
Barry S TaylorMemorial Sloan Kettering Cancer Center
Barry S TaylorMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Barry S TaylorMemorial Sloan Kettering Cancer Center
Barry S TaylorMemorial Sloan Kettering Cancer Center
Barry S TaylorMemorial Sloan Kettering Cancer Center
Barry S TaylorMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Yu ChenMemorial Sloan Kettering Cancer Center
Yu ChenMemorial Sloan Kettering Cancer Center
Yu ChenCornell University
Yu ChenMemorial Sloan Kettering Cancer Center
Yu ChenWeill Cornell Medical College
  • 1 - 11

Datasets

Release 1.2